Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes.
Extrapyramidal syndromes (EPS) impose a heavy burden on patients receiving antipsychotic therapy. Anticholinergics are the drugs of choice for preventing EPS, but they also produce many adverse reactions. Using the EPS model of haloperidol-induced catalepsy we evaluated the potential therapeutic value of a mixture of low doses of the non-selective adenosine antagonist theophylline (0.93 and 1.86 mg/kg), and the muscarinic antagonists benztropine (0.134 and 0.268 mg/kg) and ethopropazine (0.116 and 0.232 mg/kg). In rats pretreated with vehicle (distilled water), the cumulative catalepsy time over 5 h was 4199±228 s, and the mean latency was 67.5±7.8 min. Applied separately, neither of the drugs at the doses used caused significant changes of catalepsy intensity vs. control rats. However, the combination of the larger doses of theophylline and benztropine caused a significant reduction of catalepsy intensity (-41±10%) compared with the effects of the vehicle, vs. the lower dose of benztropine, and vs. both doses of theophylline alone. The mixture of the larger doses of theophylline and benztropine also delayed catalepsy onset (156±21 min) as compared with the lower doses of these same drugs applied alone. In the case of theophylline plus ethopropazine, only the association of the larger doses showed a non-significant tendency to inhibit catalepsy (-21±8%) and to prolong its latency (108±13 min). Further, neither catalepsy intensity nor its latency was affected by a combination of the selective A(1)R antagonist DPCPX (1 mg/kg), with the larger doses of both anticholinergics. In contrast, the anticholinergics showed synergism with a subthreshold dose of the selective A(2A)R antagonist ZM 241395 (0.5 mg/kg), causing a significant reduction of catalepsy intensity (ethopropazine, -27±5%; benztropine, -35±9%) and prolonging its latency (ethopropazine, 65±9 min; benztropine, 78±11 min), compared with the effect of their respective vehicle (DMSO plus mineral oil: catalepsy time, 5100±196 s; latency, 17.5±2.5 min). These findings suggest that neuroleptic-induced EPS could be effectively controlled by a combination of lower doses of theophylline and anticholinergics, with the advantage of maximizing their efficacy and minimizing their adverse reactions.
González-Lugo
Olga E
OE
Departamento de Bioquímica, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, Avenida Venustiano Carranza 2405, Colonia Los Filtros, San Luis Potosí, S.L.P., Mexico 78210.
Ceballos-Huerta
Fátima
F
Jiménez-Capdeville
María E
ME
Arankowsky-Sandoval
Gloria
G
Góngora-Alfaro
José L
JL
D000818:Animals; D001480:Basal Ganglia Diseases / Q000188:drug therapy* / Q000503:physiopathology; D002375:Catalepsy / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control*; D018680:Cholinergic Antagonists / Q000008:administration & dosage*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000633:toxicity*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D013577:Syndrome; D013806:Theophylline / Q000008:administration & dosage*; D016896:Treatment Outcome
D018680:Cholinergic Antagonists; D013806:Theophylline; D006220:Haloperidol